GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID: 31855806
Publication Date: 2019/12/13

PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis.

Desmoid-type fibromatoses (or desmoid tumors) are entities of intermediate biological potential and are locally invasive. Radical surgery, as state of the art therapy, is frequently limited by incomplete resections. Hormone modifying therapies are promising but further research is required. Poly Adenosine Diphosphate Ribose Polymerase-1 (PARP-1), a DNA repairing enzyme, might be a pathogenetic factor and could become a potential target for therapy as shown by the successful treatment of selected carcinomas and sarcomas by PARP-inhibition. In this study, we investigated the expression of estrogen receptors (ER) α (1) and β (2), progesterone receptor (PR), androgen receptor (AR), as well as PARP-1 via immunohistochemistry and quantitative RT-PCR in 69 tissue samples of desmoid tumors. Immunohistochemistry was quantified using the Immunoreactivity Score (IRS). Overall expression patterns were correlated with clinical-pathologic parameters to determine their value as a prognostic factor. Among the investigated hormone receptors only ERβ showed partial cytoplasmic reactivity. PARP-1 revealed variable nuclear positivity with IRS ranging from 0 to 6. Univariate survival analysis showed that higher expression of estrogen receptor 1 was associated with shorter disease-free survival (p = 0.005). Uni- (p = 0.03) and multivariate (p = 0.003) analyses of mRNA data revealed that higher PARP-1 expression correlated with earlier recurrence. According to this study PARP-1 expression is associated with poorer prognosis, that is faster recurrence, highlighting the possibility of PARP-1-targeting agents as a therapeutic option. Hormone receptors were of minor prognostic relevance in this study.
Authors: Bräutigam Konstantin , Lindner Judith , Budczies Jan , Pahl Stefan , Kunitz Annegret , Melcher Ingo , Wust Peter , Nebrig Maxim , Baur Alexander , Denkert Carsten , Pfitzner Berit ,


  1. [Last access 2019/12/13].

Related products :

Catalog number Product name Quantity
AS10 675 Antibody: PARP | Poly [ADP-ribose] polymerase , Immunogen: KLH-conjugated synthetic peptide derived from Arabidopsis thaliana PARP-1 (AT4G02390) and PARP-2 (AT2G31320) and PARP from other plant specie 200
31-002 CFLAR might contribute to the carcinogenesis and aggressiveness of endometrial carcinoma and might be a useful prognostic factor in the tumor. CFLAR is specially overexpressed in colon cancers and it 0.1 mg
103-M448 PARP, Host: Rat, Species: Anti-Mouse, Synonyms: Parp1; PARP; PPOL; Adprp; Adprt1; C80510; parp-1; sPARP-1; AI893648; 5830444G22Rik 100 ug
103-M448 PARP Anti-Mouse Host: Rat Parp1; PARP; PPOL; Adprp; Adprt1; C80510; parp-1; sPARP-1; AI893648; 5830444G22Rik; Poly [ADPribose] polymerase 1 100
GINS2 GINGF4 Gene gingival fibromatosis, hereditary, 4